PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Public Health Sciences, Fred Hutch Cancer Center, Seattle, WA, 98109, USA. lzhao@fredhutch.org.\', \'Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, 98109, USA.\', \'Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA.\', \'Division of Public Health Sciences, Fred Hutch Cancer Center, Seattle, WA, 98109, USA.\', \'Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, 98109, USA.\', \'Quintepa Computing LLC, Nashville, TN, USA.\', \'Department of Chemistry, Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.\', \'Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.\', \'Scisco Genetics Inc., Seattle, WA, 98102, USA.\', \'Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, 98109, USA. geraghty@fredhutch.org.\', \'Scisco Genetics Inc., Seattle, WA, 98102, USA. geraghty@fredhutch.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-04376-4
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35075180
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all